- Home
- AVDL vs LZB Comparison
AVDL vs LZB Comparison
Compare AVDL & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- LZB
- Stock Information
- Founded
- AVDL 2015
- LZB 1927
- Country
- AVDL Ireland
- LZB United States
- Employees
- AVDL N/A
- LZB N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- LZB Home Furnishings
- Sector
- AVDL Health Care
- LZB Consumer Discretionary
- Exchange
- AVDL Nasdaq
- LZB Nasdaq
- Market Cap
- AVDL 1.4B
- LZB 1.7B
- IPO Year
- AVDL 1996
- LZB N/A
- Fundamental
- Price
- AVDL $11.66
- LZB $43.70
- Analyst Decision
- AVDL Strong Buy
- LZB Hold
- Analyst Count
- AVDL 6
- LZB 1
- Target Price
- AVDL $24.00
- LZB N/A
- AVG Volume (30 Days)
- AVDL 1.7M
- LZB 451.4K
- Earning Date
- AVDL 11-12-2024
- LZB 11-19-2024
- Dividend Yield
- AVDL N/A
- LZB 1.83%
- EPS Growth
- AVDL N/A
- LZB 4.44
- EPS
- AVDL N/A
- LZB 2.90
- Revenue
- AVDL $138,160,000.00
- LZB $2,070,500,000.00
- Revenue This Year
- AVDL $533.23
- LZB $2.59
- Revenue Next Year
- AVDL $73.08
- LZB $3.95
- P/E Ratio
- AVDL N/A
- LZB $15.05
- Revenue Growth
- AVDL 1523.50
- LZB N/A
- 52 Week Low
- AVDL $10.41
- LZB $30.76
- 52 Week High
- AVDL $19.09
- LZB $45.23
- Technical
- Relative Strength Index (RSI)
- AVDL 40.12
- LZB 66.97
- Support Level
- AVDL $10.41
- LZB $41.68
- Resistance Level
- AVDL $16.66
- LZB $45.12
- Average True Range (ATR)
- AVDL 0.88
- LZB 1.17
- MACD
- AVDL -0.31
- LZB 0.26
- Stochastic Oscillator
- AVDL 20.00
- LZB 78.90
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; and Retail, which sells upholstered and case goods furniture to the end consumer. The majority of the company's revenue is derived from its Wholesale segment.